Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia [Phase 1]

View source ↗

Summary

The document provides an update on the completion of a Phase 1 clinical trial evaluating immunotoxin therapy in patients with hairy cell leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Drugs mentioned

• Immunotoxin therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia | Phase 1 | Status: COMPLETED